Searched for
GENERIC ACNE TREATMENT
Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Alembic gets USFDA nod for generic drug for skin conditionAlembic Pharmaceuticals has secured USFDA approval for its generic Tretinoin Cream USP (0.025%), a treatment for acne vulgaris. This ANDA i...
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...
- Zydus Lifesciences gets USFDA approval for generic acne treatment gelZydus Lifesciences Ltd received final approval from the US Food and Drug Administration (USFDA) to market its generic version of Dapsone ge...
- Business and valuation tailwinds to help in outperformance? 5 Indian pharma stocks with upside potential of up to 32%Just before the whole market was consumed by the PSU rally, one sector that came into the limelight after many years of underperformance wa...
- Zydus Lifesciences gets USFDA nod for generic acne-treating drugZydus Lifesciences received final approval from the US health regulator for its generic antibiotic Minocycline Hydrochloride extended-relea...
- Sun Pharma expands tie-up with Cassiopea for acne cream to six countriesAs per the tie-up, the company will receive from Cassiopea the exclusive right to develop and commercialise WINLEVI in Japan, Australia, Ne...
- Alembic Pharma gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals on Friday said its joint venture has received nod from the US health regulator for generic Adapalene gel used for t...
- Stock Analysis: One-off blues no reason to give up on Sun PharmaAnalysts have cut their price targets marginally following the hit on bottom line.
- Lupin launches tablets in US to treat infectionsThe 75 mg and 150 mg tablets were launched after receiving the approval for the from the United States Food and Drug Administration (USFDA)...
- Lupin gets USFDA nod to market anti-infections tabletsThe company has received final approval from the USFDA to market its Doxycycline hyclate tablets USP in the strength of 100 mg.
- India top source of illegal medicines entering SwitzerlandPotency preparations accounted for the maximum of the illegally imported substances that were confiscated in 2016 by Swiss customs official...
- Sun Pharmaceuticals among bidders for Bayer’s dermatology brandsPrivate equity players KKR, Nordic Capital, Bain Capital, Blackstone and Cinven may also be looking at buying the same assets.
- Sun Pharma surges after USFDA approves drug application for acne treatmentSun Pharma surged over 3% in trade today after the drug major received approval from the US health regulator for its new drug.
- Sun Pharma gets USFDA approval for acne drugSun Pharmaceutical Industries today said it has received approval from the US health regulator for its new drug application for acne treatm...
- Lupin gets USFDA nod to market generic version of CiproLupin said it has received US health regulator USFDA'S approval to market a generic version of Bayer's Cipro, used to treat infections, in ...
- Watson Laboratories send patent challenge notice to Ranbaxy for acne drugRanbaxy Laboratories' US arm has received a notice from Watson Laboratories, challenging the patent of acne treatment drug Absorica.
- GlaxoSmithKline buys US skincare firm Stiefel for $3.6 bnBritish drugs firm GlaxoSmithKline (GSK) said Monday it will buy Stiefel Laboratories, US maker of anti-itching creams, acne treatments and...
Load More
